Skip to main content
Erschienen in: Diseases of the Colon & Rectum 5/2007

01.05.2007

Patient Preferences Between Surgical and Medical Treatment in Crohn’s Disease

verfasst von: Christopher M. Byrne, M.B.B.S., B.Sc.(Med.), M.S., F.R.A.C.S., Michael J. Solomon, M.B.B.Ch.(Hons.), M.Sc., F.R.A.C.S., Jane M. Young, M.B.B.S., M.P.H., Ph.D., F.A.F.P.H.M., Warwick Selby, M.B.B.S., F.R.A.C.P., James D. Harrison, B.Sc.(Hons.), M.P.H.

Erschienen in: Diseases of the Colon & Rectum | Ausgabe 5/2007

Einloggen, um Zugang zu erhalten

Purpose

Crohn’s disease poses difficult choices in which the most appropriate treatment option is not always obvious. When this state of uncertainty exists, patients’ preferences should have an increasingly important part of clinical decision making. The purpose of this study was to compare patients’ preferences for surgical intervention in Crohn’s disease with the preferences of surgeons and gastroenterologists.

Methods

Outpatients with Crohn’s disease were interviewed to quantify their preferences for six scenarios by using the prospective preference measure. An identical questionnaire was mailed to all Australian and New Zealand colorectal surgeons and a random sample of 300 Australian gastroenterologists.

Results

Forty-one of 123 patients with Crohn’s disease (33 percent), 92 of 127 colorectal surgeons (72 percent), and 74 of 272 gastroenterologists (27 percent) participated. There were significant differences between patients and gastroenterologists for three of six scenarios and between surgeons and gastroenterologists in four of six scenarios. Seventy-six percent of gastroenterologists were willing to gamble to avoid an ileocolic resection compared with 37 percent of surgeons (chi-squared = 25.44; P < 0.0001) and 39 percent of patients (chi-squared = 15.44; P < 0.001).

Conclusions

Patients and clinicians were able to trade and gamble life expectancy as a measure of preference for varying hypothetical surgical treatments, even though these treatment options impacted on quality of life rather than survival. Patients’ preferences did not align with clinicians. For most scenarios, colorectal surgeons’ preferences were significantly different to those of gastroenterologists.
Literatur
1.
Zurück zum Zitat Solem, CA, Loftus, EV 2004Management of refractory inflammatory bowel diseaseGastroenterol Clin North Am33319324PubMedCrossRef Solem, CA, Loftus, EV 2004Management of refractory inflammatory bowel diseaseGastroenterol Clin North Am33319324PubMedCrossRef
2.
Zurück zum Zitat Lofberg, R 2003Review article: medical treatment of mild to moderately active Crohn’s diseaseAliment Pharmacol Ther171822PubMedCrossRef Lofberg, R 2003Review article: medical treatment of mild to moderately active Crohn’s diseaseAliment Pharmacol Ther171822PubMedCrossRef
3.
Zurück zum Zitat Warman, J, Korelitz, B, Fleisher, M, Janardhanam, R 2003Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn’s disease and ulcerative colitisJ Clin Gastroenterol37220225PubMedCrossRef Warman, J, Korelitz, B, Fleisher, M, Janardhanam, R 2003Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn’s disease and ulcerative colitisJ Clin Gastroenterol37220225PubMedCrossRef
4.
Zurück zum Zitat Yang, Y, Lichtenstein, G 2002Corticosteroids in Crohn’s diseaseAm J Gastroenterol97803823PubMedCrossRef Yang, Y, Lichtenstein, G 2002Corticosteroids in Crohn’s diseaseAm J Gastroenterol97803823PubMedCrossRef
5.
Zurück zum Zitat Blomqvist, P, Feltelius, N, Lofberg, R, Ekbom, A 2001A 10-year survey of inflammatory bowel diseases-drug therapy, costs and adverse reactionsAliment Pharmacol Ther15475481PubMedCrossRef Blomqvist, P, Feltelius, N, Lofberg, R, Ekbom, A 2001A 10-year survey of inflammatory bowel diseases-drug therapy, costs and adverse reactionsAliment Pharmacol Ther15475481PubMedCrossRef
6.
Zurück zum Zitat Sandborn W, Sutherland L, Pearson D, et al. Azathioprine or 6-mercaptopurine for inducing remission of Crohn’s disease. Cochrane database of Systematic Reviews. Edition 2; www.thecochranelibrary.com. Accessed 23 August 2005 Sandborn W, Sutherland L, Pearson D, et al. Azathioprine or 6-mercaptopurine for inducing remission of Crohn’s disease. Cochrane database of Systematic Reviews. Edition 2; www.​thecochranelibra​ry.​com. Accessed 23 August 2005
7.
Zurück zum Zitat Stuck, A, Minder, C, Frey, F 1989Risk of infectious complications in patients taking glucocorticosteroidsRev Infect Dis11954963PubMed Stuck, A, Minder, C, Frey, F 1989Risk of infectious complications in patients taking glucocorticosteroidsRev Infect Dis11954963PubMed
8.
Zurück zum Zitat Rutgeerts, P, Assche, G, Vermeire, S 2004Optimizing anti-TNF treatment in inflammatory bowel diseaseGastroenterology12615931610PubMedCrossRef Rutgeerts, P, Assche, G, Vermeire, S 2004Optimizing anti-TNF treatment in inflammatory bowel diseaseGastroenterology12615931610PubMedCrossRef
9.
Zurück zum Zitat Sands, BE, Anderson, FH, Bernstein, CN, et al. 2004Infliximab maintenance therapy for fistulizing Crohn’s diseaseN Engl J Med350876885PubMedCrossRef Sands, BE, Anderson, FH, Bernstein, CN,  et al. 2004Infliximab maintenance therapy for fistulizing Crohn’s diseaseN Engl J Med350876885PubMedCrossRef
10.
Zurück zum Zitat Sandborn, WJ, Hanauer, SB 2002Infliximab in the treatment of Crohn’s disease: a user’s guide for cliniciansAm J Gastroenterol9729622972PubMedCrossRef Sandborn, WJ, Hanauer, SB 2002Infliximab in the treatment of Crohn’s disease: a user’s guide for cliniciansAm J Gastroenterol9729622972PubMedCrossRef
11.
Zurück zum Zitat Colombel, J, Loftus, EJ, Tremaine, W, et al. 2004The safety profile of infliximab in patients with Crohn’s disease: the Mayo Clinic experience in 500 patientsGastroenterology1261931PubMedCrossRef Colombel, J, Loftus, EJ, Tremaine, W,  et al. 2004The safety profile of infliximab in patients with Crohn’s disease: the Mayo Clinic experience in 500 patientsGastroenterology1261931PubMedCrossRef
12.
Zurück zum Zitat Bernell, O, Lapidus, A, Hellers, G 2000Risk factors for surgery and postoperative recurrence in Crohn’s diseaseAnn Surg2313845PubMedCrossRef Bernell, O, Lapidus, A, Hellers, G 2000Risk factors for surgery and postoperative recurrence in Crohn’s diseaseAnn Surg2313845PubMedCrossRef
13.
Zurück zum Zitat Bernell, O, Lapidus, A, Hellers, G 2001Recurrence after colectomy in Crohn’s colitisDis Colon Rectum44647654PubMedCrossRef Bernell, O, Lapidus, A, Hellers, G 2001Recurrence after colectomy in Crohn’s colitisDis Colon Rectum44647654PubMedCrossRef
14.
Zurück zum Zitat Thompson-Fawcett, MW, Mortensen, NJ 1998Crohn’s diseasePhillips, RK eds. Colorectal surgery: companion to specialist colorectal surgical practiceWB SaundersLondon179216 Thompson-Fawcett, MW, Mortensen, NJ 1998Crohn’s diseasePhillips, RK eds. Colorectal surgery: companion to specialist colorectal surgical practiceWB SaundersLondon179216
15.
Zurück zum Zitat Regimbeau, JM, Panis, Y, Pocard, M, et al. 2001Long-term results of ileal pouch-anal anastomosis for colorectal Crohn’s diseaseDis Colon Rectum44769779PubMedCrossRef Regimbeau, JM, Panis, Y, Pocard, M,  et al. 2001Long-term results of ileal pouch-anal anastomosis for colorectal Crohn’s diseaseDis Colon Rectum44769779PubMedCrossRef
16.
Zurück zum Zitat Salkeld, G, Solomon, MJ 2003An economic perspective on evidence-based patient choice in surgeryANZ J Surg73427430PubMedCrossRef Salkeld, G, Solomon, MJ 2003An economic perspective on evidence-based patient choice in surgeryANZ J Surg73427430PubMedCrossRef
17.
Zurück zum Zitat Solomon, MJ, Pager, CK, Keshava, A, et al. 2003What do patients want? Patient preferences and surrogate decision making in the treatment of colorectal cancerDis Colon Rectum4613511357PubMedCrossRef Solomon, MJ, Pager, CK, Keshava, A,  et al. 2003What do patients want? Patient preferences and surrogate decision making in the treatment of colorectal cancerDis Colon Rectum4613511357PubMedCrossRef
18.
Zurück zum Zitat Suarez-Almazor, ME, Conner-Spady, B, Kendall, CJ, Russell, AS, Skeith, K 2001Lack of congruence in the ratings of patients’ health status by patients and their physiciansMed Decis Making21113121PubMedCrossRef Suarez-Almazor, ME, Conner-Spady, B, Kendall, CJ, Russell, AS, Skeith, K 2001Lack of congruence in the ratings of patients’ health status by patients and their physiciansMed Decis Making21113121PubMedCrossRef
19.
Zurück zum Zitat Bruera, E, Willey, JS, Palmer, JL, Rosales, M 2002Treatment decisions for breast carcinoma - patient preferences and physician perceptionsCancer9420762080PubMedCrossRef Bruera, E, Willey, JS, Palmer, JL, Rosales, M 2002Treatment decisions for breast carcinoma - patient preferences and physician perceptionsCancer9420762080PubMedCrossRef
20.
Zurück zum Zitat Butow, PN, Maclean, M, Dunn, SM 1997The dynamics of change: cancer patients’ preferences for information, involvement and supportAnn Oncol8857863PubMedCrossRef Butow, PN, Maclean, M, Dunn, SM 1997The dynamics of change: cancer patients’ preferences for information, involvement and supportAnn Oncol8857863PubMedCrossRef
21.
Zurück zum Zitat Stiggelbout, AM, Kiebert, GM 1997A role for the sick role. Patient preferences regarding information and participation in clinical decision-makingCMAJ157383389PubMed Stiggelbout, AM, Kiebert, GM 1997A role for the sick role. Patient preferences regarding information and participation in clinical decision-makingCMAJ157383389PubMed
22.
Zurück zum Zitat Protheroe, J, Fahey, T, Montgomery, AA, Peters, TJ 2000The impact of patients’ preferences on the treatment of atrial fibrillation: observational study of patient based decision analysisBMJ32013801384PubMedCrossRef Protheroe, J, Fahey, T, Montgomery, AA, Peters, TJ 2000The impact of patients’ preferences on the treatment of atrial fibrillation: observational study of patient based decision analysisBMJ32013801384PubMedCrossRef
23.
Zurück zum Zitat Ramfelt, E, Langius, A, Bjorvell, H, Nordstrom, G 2000Treatment decision-making and its relation to the sense of coherence and the meaning of the disease in a group of patients with colorectal cancerEur J Cancer Care (Engl)9158166CrossRef Ramfelt, E, Langius, A, Bjorvell, H, Nordstrom, G 2000Treatment decision-making and its relation to the sense of coherence and the meaning of the disease in a group of patients with colorectal cancerEur J Cancer Care (Engl)9158166CrossRef
24.
Zurück zum Zitat Henman, MJ, Butow, PN, Brown, RF 2002Lay constructions of decision-making in cancerPsychooncology11295306PubMedCrossRef Henman, MJ, Butow, PN, Brown, RF 2002Lay constructions of decision-making in cancerPsychooncology11295306PubMedCrossRef
25.
Zurück zum Zitat Kennedy, E, Urbach, D, Krahn, M, et al. 2004Azathioprine or ileocolic resection for steroid-dependent terminal ileal Crohn’s disease? A Markov analysisDis Colon Rectum4721202130PubMedCrossRef Kennedy, E, Urbach, D, Krahn, M,  et al. 2004Azathioprine or ileocolic resection for steroid-dependent terminal ileal Crohn’s disease? A Markov analysisDis Colon Rectum4721202130PubMedCrossRef
26.
Zurück zum Zitat Sonnenberg, A, Gavin, MW 2000Timing of surgery for enterovesical fistula in Crohn’s disease: decision analysis using a time-dependent compartment modelInflamm Bowel Dis6280285PubMedCrossRef Sonnenberg, A, Gavin, MW 2000Timing of surgery for enterovesical fistula in Crohn’s disease: decision analysis using a time-dependent compartment modelInflamm Bowel Dis6280285PubMedCrossRef
27.
Zurück zum Zitat Kennedy, ED, Detsky, AS, Llewellyn-Thomas, HA, et al. 2000Can the standard gamble be used to determine utilities for uncertain health states? An example using postoperative maintenance therapy in Crohn’s diseaseMed Decis Making207278PubMedCrossRef Kennedy, ED, Detsky, AS, Llewellyn-Thomas, HA,  et al. 2000Can the standard gamble be used to determine utilities for uncertain health states? An example using postoperative maintenance therapy in Crohn’s diseaseMed Decis Making207278PubMedCrossRef
28.
Zurück zum Zitat Kennedy ED, To T, Steinhart AH, et al. Is the probability trade off a reliable and valid measure for use in young populations with chronic disease? Annual Meeting of Society for Medical Decision Making. Cincinnati, OH: October 2000 Kennedy ED, To T, Steinhart AH, et al. Is the probability trade off a reliable and valid measure for use in young populations with chronic disease? Annual Meeting of Society for Medical Decision Making. Cincinnati, OH: October 2000
29.
Zurück zum Zitat McLeod, RS, Baxter, NN 1998Quality of life of patients with inflammatory bowel disease after surgeryWorld J Surg22375381PubMedCrossRef McLeod, RS, Baxter, NN 1998Quality of life of patients with inflammatory bowel disease after surgeryWorld J Surg22375381PubMedCrossRef
30.
Zurück zum Zitat Stiggelbout, AM, Haes, JC 2001Patient preference for cancer therapy: an overview of measurement approachesJ Clin Oncol19220230PubMed Stiggelbout, AM, Haes, JC 2001Patient preference for cancer therapy: an overview of measurement approachesJ Clin Oncol19220230PubMed
31.
Zurück zum Zitat Edwards, P, Roberts, I, Clarke, I, et al. 2002Increasing response rates in postal questionnaires: systematic reviewBMJ32411831191PubMedCrossRef Edwards, P, Roberts, I, Clarke, I,  et al. 2002Increasing response rates in postal questionnaires: systematic reviewBMJ32411831191PubMedCrossRef
33.
Zurück zum Zitat SPSS I. SPSS Base. Chicago, IL: SPSS Inc., 2004;12.0.1 SPSS I. SPSS Base. Chicago, IL: SPSS Inc., 2004;12.0.1
34.
Zurück zum Zitat Hanauer, S, Feagan, B, Lichtenstein, G, et al. 2002Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trialLancet35915411549PubMedCrossRef Hanauer, S, Feagan, B, Lichtenstein, G,  et al. 2002Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trialLancet35915411549PubMedCrossRef
35.
Zurück zum Zitat Seiderer, J, Goke, B, Ochsenkuhn, T 2000Safety aspects of infliximab in inflammatory bowel disease patients. A retrospective cohort study in 100 patients of a German University HospitalDigestion7039CrossRef Seiderer, J, Goke, B, Ochsenkuhn, T 2000Safety aspects of infliximab in inflammatory bowel disease patients. A retrospective cohort study in 100 patients of a German University HospitalDigestion7039CrossRef
36.
Zurück zum Zitat Boyd, NF, Sutherland, HJ, Heasman, KZ, Tricthler, DL, Cummings, BJ 1990Whose utilities for decision analysis?Med Decis Making105867PubMedCrossRef Boyd, NF, Sutherland, HJ, Heasman, KZ, Tricthler, DL, Cummings, BJ 1990Whose utilities for decision analysis?Med Decis Making105867PubMedCrossRef
37.
Zurück zum Zitat King, JT, Tsevat, J, Roberts, MS 2004Positive association between current health and health values for hypothetical disease statesMed Decis Making24367378PubMedCrossRef King, JT, Tsevat, J, Roberts, MS 2004Positive association between current health and health values for hypothetical disease statesMed Decis Making24367378PubMedCrossRef
38.
Zurück zum Zitat Hartley, JE, Fazio, VW, Remzi, FH, et al. 2004Analysis of the outcome of ileal pouch-anal anastomosis in patients with Crohn’s diseaseDis Colon Rectum4718051811 Hartley, JE, Fazio, VW, Remzi, FH,  et al. 2004Analysis of the outcome of ileal pouch-anal anastomosis in patients with Crohn’s diseaseDis Colon Rectum4718051811
39.
Zurück zum Zitat Randolph, A, Zollo, M, Egger, M, et al. 1999Variability in physician opinion on limiting pediatric life supportPediatrics103807808CrossRef Randolph, A, Zollo, M, Egger, M,  et al. 1999Variability in physician opinion on limiting pediatric life supportPediatrics103807808CrossRef
40.
Zurück zum Zitat Scott, NA, Hughes, LE 1994Timing of ileocolonic resection for symptomatic Crohn’s disease - the patient’s viewGut35656657PubMed Scott, NA, Hughes, LE 1994Timing of ileocolonic resection for symptomatic Crohn’s disease - the patient’s viewGut35656657PubMed
41.
Zurück zum Zitat Delaney, CP, Kiran, RP, Senagore, AJ, et al. 2003Quality of life improves within 30 days of surgery for Crohn’s diseaseJ Am Coll Surg196714721PubMedCrossRef Delaney, CP, Kiran, RP, Senagore, AJ,  et al. 2003Quality of life improves within 30 days of surgery for Crohn’s diseaseJ Am Coll Surg196714721PubMedCrossRef
42.
Zurück zum Zitat Chew, SS, Ngo, TQ, Douglas, PR, et al. 2003Cholecystectomy in patients with Crohn’s ileitisDis Colon Rectum4614841488PubMedCrossRef Chew, SS, Ngo, TQ, Douglas, PR,  et al. 2003Cholecystectomy in patients with Crohn’s ileitisDis Colon Rectum4614841488PubMedCrossRef
43.
Zurück zum Zitat Junghans, C, Feder, G, Hemingway, H, Timmis, A, Jones, M 2005Recruiting patients to medical research: double blind randomised trial of “opt-in” versus “opt-out” strategiesBMJ331940944PubMedCrossRef Junghans, C, Feder, G, Hemingway, H, Timmis, A, Jones, M 2005Recruiting patients to medical research: double blind randomised trial of “opt-in” versus “opt-out” strategiesBMJ331940944PubMedCrossRef
44.
Zurück zum Zitat Stiggelbout, AM, Kiebert, GM, Kievit, J, et al. 1994Utility assessment in cancer patients: adjustment of time tradeoff scores for the utility of life years and comparison with standard gamble scoresMed Decis Making148290PubMedCrossRef Stiggelbout, AM, Kiebert, GM, Kievit, J,  et al. 1994Utility assessment in cancer patients: adjustment of time tradeoff scores for the utility of life years and comparison with standard gamble scoresMed Decis Making148290PubMedCrossRef
45.
Zurück zum Zitat Souchek, J, Stacks, J, Brody, B, et al. 2000A trial for comparing methods for eliciting treatment preferences from men with advanced prostate cancer: results from the initial visitMed Care3810401050PubMedCrossRef Souchek, J, Stacks, J, Brody, B,  et al. 2000A trial for comparing methods for eliciting treatment preferences from men with advanced prostate cancer: results from the initial visitMed Care3810401050PubMedCrossRef
47.
Zurück zum Zitat Brownstein, AL 2003Biased predecision processingPsych Bull129545568CrossRef Brownstein, AL 2003Biased predecision processingPsych Bull129545568CrossRef
Metadaten
Titel
Patient Preferences Between Surgical and Medical Treatment in Crohn’s Disease
verfasst von
Christopher M. Byrne, M.B.B.S., B.Sc.(Med.), M.S., F.R.A.C.S.
Michael J. Solomon, M.B.B.Ch.(Hons.), M.Sc., F.R.A.C.S.
Jane M. Young, M.B.B.S., M.P.H., Ph.D., F.A.F.P.H.M.
Warwick Selby, M.B.B.S., F.R.A.C.P.
James D. Harrison, B.Sc.(Hons.), M.P.H.
Publikationsdatum
01.05.2007
Erschienen in
Diseases of the Colon & Rectum / Ausgabe 5/2007
Print ISSN: 0012-3706
Elektronische ISSN: 1530-0358
DOI
https://doi.org/10.1007/s10350-006-0847-0

Weitere Artikel der Ausgabe 5/2007

Diseases of the Colon & Rectum 5/2007 Zur Ausgabe

OriginalPaper

Selected Abstracts

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.